By Iain Gilbert
Date: Tuesday 22 Jul 2025
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it plans to invest $50.0bn in the US for medicines manufacturing and R&D by 2030.
AstraZeneca said its investment will support its ambition to reach $80.0bn in revenues by 2030, with 50% generated in the US, and was expected to create tens...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news